<table border="single" id="id_b63b8040-58d2-4d8c-bd87-23bab36bce6f" width="428" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_ec5ebeac-fc0e-49da-8e18-4eb59421b868">Table 1: Select Mean (± S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin Hydrochloride tablet </caption>
<col width="42.3%"></col>
<col width="20.0%"></col>
<col width="18.9%"></col>
<col width="18.9%"></col>
<tbody>
<tr id="id_c702c43f-444e-4e39-b862-3c772d0e29ca">
<td align="justify" stylecode="Botrule Toprule Rrule Lrule" valign="top">
<paragraph>
<content stylecode="bold">Subject Groups: Metformin hydrochloride tablet</content>
</paragraph>
<content stylecode="bold">dose<footnote id="id-20d8fe6b-9da1-499f-a59f-68b4cb515da7"> All doses given fasting except the first 18 doses of the multiple dose studies</footnote>  (number of subjects)</content>
</td>
<td align="justify" stylecode="Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">       C<sub>max</sub>
<footnote id="id-c5fadf3a-c337-4e5f-b382-36d7a45ba95c"> Peak plasma concentration</footnote>
</content>
</paragraph>
<content stylecode="bold">       ( µg/mL)</content>
</td>
<td align="justify" stylecode="Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">        T<sub>max</sub>
<footnote id="id-224356b2-52dd-4a58-9f84-4c20d2b1733f"> Time to peak plasma concentration</footnote>
</content>
</paragraph>
<content stylecode="bold">            (hrs)</content>
</td>
<td align="justify" stylecode="Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">    Renal     </content>
</paragraph>
<paragraph>
<content stylecode="bold">   Clearance          </content>
</paragraph>
<content stylecode="bold">   (mL/min)</content>
</td>
</tr>
<tr id="id_ad7c6083-928f-477a-83c9-361f5113f8fa">
<td align="justify" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">Healthy, nondiabetic adults:</content>
</paragraph>
<paragraph>500 mg single dose (24)</paragraph>
<paragraph>850 mg single dose (74) <footnote id="id-c46effe3-3dba-4e6f-8190-801dd052daa1"> Combined results (average means) of five studies: mean age 32 years (range 23-59 years)</footnote>
</paragraph>
  850 mg three times daily for 19 doses<sup>e</sup> (9)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>1.03 ( ± 0.33)</paragraph>
<paragraph>1.60 (± 0.38)</paragraph>
  2.01 (± 0.42)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>2.75 (± 0.81)</paragraph>
<paragraph>2.64 (± 0.82)</paragraph>
  1.79 (± 0.94)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>600 (± 132)</paragraph>
<paragraph>552 (± 139)</paragraph>
  642 (± 173)</td>
</tr>
<tr id="id_60ba9ab4-b0bc-4e3d-bdc4-c3f7e0366e46">
<td align="justify" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">Adults with type 2 diabetes:</content>
</paragraph>
<paragraph>850 mg single dose (23)</paragraph>
<paragraph>850 mg three times daily for</paragraph>
  19 doses<footnote id="id-2bb1c0bc-facc-49af-878b-c7d6365bba76"> Kinetic study done following dose 19, given fasting</footnote> (9)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>1.48 (± 0.5)</paragraph>
  1.90 (± 0.62)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>3.32 (±1.08)</paragraph>
  2.01 (±1.22)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>491 (± 138)</paragraph>
  550 (± 160)</td>
</tr>
<tr id="id_db2ae787-39ac-450f-bfe0-3d26509dd72b">
<td align="justify" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">Elderly<footnote id="id-57ecd1ed-e9c7-4b6e-acf3-265bf361c309"> Elderly subjects, mean age 71 years (range 65-81 years)</footnote>, <content stylecode="bold">healthy nondiabetic adults:</content>
</content>
</paragraph>
<paragraph>  850 mg single dose (12)</paragraph>
</td>
<td align="center" stylecode="Botrule Rrule" valign="top">2.45 (± 0.70)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">2.71 (± 1.05)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">412 (± 98)</td>
</tr>
<tr id="id_810dd846-1d43-476d-b7bb-c41a7199a145">
<td align="justify" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">Renal-impaired adults: </content>
</paragraph>
<paragraph>
<content stylecode="bold">850 mg single dose </content>
</paragraph>
<paragraph>
<content stylecode="bold">Mild</content> (CL<sub>cr</sub>
<footnote id="id-a11792f7-8860-48ce-aefd-5359472a3c38"> CL<sub>cr</sub> = creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup>
</footnote> 61-90 mL/min) (5)</paragraph>
<paragraph>
<content stylecode="bold">Moderate</content>(CL<sub>cr</sub> 31-60 mL/min) (4)</paragraph>
<content stylecode="bold">Severe</content> (CL<sub>cr</sub> 10-30 mL/min) (6)</td>
<td align="center" stylecode="Rrule" valign="top">
<paragraph>1.86(±0.52)</paragraph>
<paragraph>4.12(±1.83)</paragraph>
  3.93(±0.92)</td>
<td align="center" stylecode="Rrule" valign="top">
<paragraph>3.20(±0.45)</paragraph>
<paragraph>3.75(±0.50)</paragraph>
  4.01(±1.10)</td>
<td align="center" stylecode="Botrule Rrule" valign="top">
<paragraph>  384 (± 122)</paragraph>
<paragraph>108 (± 57)</paragraph>
  130 (± 90)</td>
</tr>
</tbody>
</table>